Literature DB >> 6777806

Anxiety and sedation during a stressful situation after single dose of diazepam versus N-desmethyldiazepam--a controlled trial.

J Hendel, P Elsass, K H Sørensen, I W Møller, E F Hvidberg, T Hansen.   

Abstract

Twenty milligram diazepam (DZ) was compared with 20 mg of its main metabolite N-desmethyldiazepam (NDDZ) as single dose, oral premedication in a genuine stressful situation. Fifty patients participated in the randomized, double-blind controlled study. Anxiety and sedation were measured the day before an operation and one hour after premedication, just before the operation. NDDZ was significantly less sedative while the degree of anxiety was rated equal in the two groups. The results may support the hypothesis that a competition between DZ and NDDZ can explain the shift in the effect profile of DZ during long term treatment.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6777806     DOI: 10.1007/bf00427891

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  11 in total

1.  Cumulation in cerebrospinal fluid of the N-desmethyl metabolite after long-term treatment with diazepam in man.

Authors:  J Hendel
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1975-07

2.  A simple method for determining diazepam and its major metabolites in biological fluids: application in bioavailability studies.

Authors:  E Arnold
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1975-04

3.  Diazepam metabolism in normal man. II. Serum concentration and clinical effect after oral administration and cumulation.

Authors:  L Hillestad; T Hansen; H Melsom
Journal:  Clin Pharmacol Ther       Date:  1974-09       Impact factor: 6.875

4.  Plasma concentrations of diazepam and of its metabolite N-desmethyldiazepam in relation to anxiolytic effect.

Authors:  H H Dasberg; E van der Kleijn; J P Guelen; H M van Praag
Journal:  Clin Pharmacol Ther       Date:  1974-05       Impact factor: 6.875

5.  Plasma level of diazepam as a therapeutic predictor in anxiety states.

Authors:  G N Bianchi; M R Fennessy; J Phillips; B S Everitt
Journal:  Psychopharmacologia       Date:  1974-02-15

6.  Concentration-effect relationships with major and minor tranquilizers.

Authors:  S H Curry
Journal:  Clin Pharmacol Ther       Date:  1974-07       Impact factor: 6.875

7.  Determination of bioavailability of diazepam in various formulations from steady state plasma concentration data.

Authors:  A Berlin; B Siwers; S Agurell; A Hiort; F Sjöqvist; S Ström
Journal:  Clin Pharmacol Ther       Date:  1972 Sep-Oct       Impact factor: 6.875

8.  Physiological and psychological effects of clorazepate in man.

Authors:  M H Lader; S Curry; W J Baker
Journal:  Br J Clin Pharmacol       Date:  1980-01       Impact factor: 4.335

9.  Effects and plasma levels of N-desmethyldiazepam after oral administration in normal volunteers.

Authors:  H H Dasberg
Journal:  Psychopharmacologia       Date:  1975-08-21

10.  Kinetics and neuropsychologic effects of IV diazepam in the presence and absence of its active N-desmethyl metabolite in humans.

Authors:  P Elsass; J Hendel; E F Hvidberg; T Hansen; E Gymoese; J Rathje
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

View more
  2 in total

1.  Development of tolerance and cross-tolerance to the psychomotor actions of lorazepam and diazepam in man.

Authors:  K Aranko; M J Mattila; T Seppälä
Journal:  Br J Clin Pharmacol       Date:  1983-05       Impact factor: 4.335

2.  Kinetics and neuropsychologic effects of IV diazepam in the presence and absence of its active N-desmethyl metabolite in humans.

Authors:  P Elsass; J Hendel; E F Hvidberg; T Hansen; E Gymoese; J Rathje
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.